Common use of USE OF DISPLAY SPACE Clause in Contracts

USE OF DISPLAY SPACE. A representative of the participating company must always be present at the Supplier Suite/Collaboration Kiosk(s) during the posted Event hours. Except for book publishers, the sale of merchandise or equipment of any kind is prohibited. The use of the Convening Organization(s) logo on displays, signs, giveaways, promotional literature or other material is strictly prohibited. In addition, the use of the acronym of the Convening Organization must not be used on pre, at-show and/or post show promotional material unless specific written permission is granted. Use of any Convener, Sponsor or other logos is strictly prohibited unless permission is granted directly from those organizations in writing. Signs or other articles are prohibited from being fastened to the walls, pillars or electrical fixtures. The use of thumbtacks, tape, nails, screws, bolts or any other tool or material which could mar the floor or walls is prohibited. Drip pans must be used under all equipment where there is a possibility of leakage. No helium-filled balloons or adhesive-backed stickers may be used or given out by Suppliers. Because this is a networking and education focused forum, there will be no equipment or machinery allowed on display in the Supplier Suite or at your Collaboration Kiosk, unless approved by SHOW MANAGEMENT. FDA APPROVAL/CLEARANCE: If a Supplier intends to display, introduce or feature an article whose pre-market approval or clearance is pending from the U.S. Food & Drug Administration, the Supplier’s materials, and the Supplier’s personnel must disclose that such article has not received final FDA approval/clearance and clearly conveyed the status of such article consistent with such laws, rules and regulations administrated by the FDA. The Supplier Suite or Collaboration Kiosk displays and any associated materials also must adequately and completely disclose that the article is not currently available for sale or commercial distribution in the U.S. shall indemnify and hold harmless SHOW MANAGEMENT and the Convening Organization(s) from and against any and all costs, fees, expenses, penalties, damages and claims arising from Supplier’s failure to comply with all laws, rules and regulations (including those of FDA) applicable to such article (including any law, rule or regulation governing the display, introduction, or advertising of such article prior to final FDA approval/clearance).

USE OF DISPLAY SPACE. A representative Upon acceptance of this agreement by ICI, exhibitor will receive notice of space assignment. ICI shall be solely responsible for the assignment of all Exhibit Hall space and reserves the right to relocate display areas/exhibit booths as it deems necessary. By signing this document, exhibitor agrees to conform its participation in the conference to the provisions listed below. Violations are grounds for expulsion from the exhibit area and/or restriction from participation in future exhibitions. » Displays will be installed and ready to exhibit two hours before the time set for opening the exhibition. » Exhibit booths must be statted at all times during the official Exhibit Hall hours. » All booth equipment, product samples, demonstrations, and distribution of materials must be confined to the physical limits of the participating company exhibit booth. No posting or circulation of materials is permitted outside the exhibit booth. » Exhibitor shall not assign, sublet, or share the space assigned to it without the prior written approval of ICI. » Exhibits that include the operation of musical instruments, radios, talking motion pictures, etc., must always have ICI’s prior written approval to operate. Public address systems/microphones may not be present operated in any exhibit space. Any sound or light must not annoy or disturb adjacent exhibitors and their patrons. ICI reserves the right to rescind prior written approval of any sound or light that subsequently proves to be a disturbance to adjacent vendors or to the Exhibit Hall in general. » ICI reserves the right to monitor the distribution of complimentary gifts within the Exhibit Hall and may restrict certain promotions if deemed inappropriate for the conference. » No surveys, research, or other forms of data gathering—whether or not conducted with the intent to announce or publish the results of such survey or data gathering—either during or after the conference, can take place in the Exhibit Hall or at the Supplier Suite/Collaboration Kiosk(s) during the posted Event hoursconference without prior written approval of ICI. Except for book publishers, the sale of merchandise » No conference facility or equipment of any kind is prohibited. The use of the Convening Organization(s) logo on displays, signs, giveaways, promotional literature or other material is strictly prohibited. In addition, the use of the acronym of the Convening Organization must not be used on pre, at-show and/or post show promotional material unless specific written permission is granted. Use of any Convener, Sponsor or other logos is strictly prohibited unless permission is granted directly from those organizations in writing. Signs or other articles are prohibited from being fastened to the walls, pillars or electrical fixtures. The use of thumbtacks, tape, nails, screws, bolts or any other tool or material which could mar the floor or walls is prohibited. Drip pans must be used under all equipment where there is a possibility of leakage. No helium-filled balloons or adhesive-backed stickers hotel space may be used by exhibitor or given out by Suppliersany of its affiliated organizations for any business, social, or other event without the prior written approval of ICI. Because this is a networking and education focused forumNo functions may conflict with the conference’s meeting agenda, there will be no equipment or machinery allowed on display in the Supplier Suite or at your Collaboration KioskExhibit Hall hours, unless approved by SHOW MANAGEMENT. FDA APPROVAL/CLEARANCE: If a Supplier intends to display, introduce or feature an article whose pre-market approval or clearance is pending from the U.S. Food & Drug Administration, the Supplier’s materialsconference registration, and the Supplier’s personnel must disclose that such article has not received final FDA approvalreception/ dinner times. INSTALLATION/clearance and clearly conveyed the status of such article consistent with such lawsDISMANTLING AND EXHIBIT HOURS Tuesday, rules and regulations administrated by the FDA. The Supplier Suite or Collaboration Kiosk displays and any associated materials also must adequately and completely disclose that the article is not currently available for sale or commercial distribution in the U.S. shall indemnify and hold harmless SHOW MANAGEMENT and the Convening Organization(s) from and against any and all costs, fees, expenses, penalties, damages and claims arising from Supplier’s failure to comply with all laws, rules and regulations (including those of FDA) applicable to such article (including any law, rule or regulation governing the display, introduction, or advertising of such article prior to final FDA approval/clearance).November 7 8:00 a.m.–4:00 p.m.

USE OF DISPLAY SPACE. A representative Upon acceptance of this agreement by ICI, exhibitor will receive notice of space assignment. ICI shall be solely responsible for the assignment of all Exhibit Hall space and reserves the right to relocate display areas/exhibit booths as it deems necessary. By signing this document, exhibitor agrees to conform its participation in the conference to the provisions listed below. Violations are grounds for expulsion from the exhibit area and/or restriction from participation in future exhibitions. » Displays will be installed and ready to exhibit two hours before the time set for opening the exhibition. » Exhibit booths must be staffed at all times during the official Exhibit Hall hours. » All booth equipment, product samples, demonstrations, and distribution of materials must be confined to the physical limits of the participating company exhibit booth. No posting or circulation of materials is permitted outside the exhibit booth. » Exhibitor shall not assign, sublet, or share the space assigned to it without the prior written approval of ICI. » Exhibits that include the operation of musical instruments, radios, talking motion pictures, etc., must always have ICI’s prior written approval to operate. Public address systems/microphones may not be present operated in any exhibit space. Any sound or light must not annoy or disturb adjacent exhibitors and their patrons. ICI reserves the right to rescind prior written approval of any sound or light that subsequently proves to be a disturbance to adjacent vendors or to the Exhibit Hall in general. » ICI reserves the right to monitor the distribution of complimentary gifts within the Exhibit Hall and may restrict certain promotions if deemed inappropriate for the conference. » No surveys, research, or other forms of data gathering—whether or not conducted with the intent to announce or publish the results of such survey or data gathering—either during or after the conference, can take place in the Exhibit Hall or at the Supplier Suite/Collaboration Kiosk(s) during the posted Event hoursconference without prior written approval of ICI. Except for book publishers, the sale of merchandise » No conference facility or equipment of any kind is prohibited. The use of the Convening Organization(s) logo on displays, signs, giveaways, promotional literature or other material is strictly prohibited. In addition, the use of the acronym of the Convening Organization must not be used on pre, at-show and/or post show promotional material unless specific written permission is granted. Use of any Convener, Sponsor or other logos is strictly prohibited unless permission is granted directly from those organizations in writing. Signs or other articles are prohibited from being fastened to the walls, pillars or electrical fixtures. The use of thumbtacks, tape, nails, screws, bolts or any other tool or material which could mar the floor or walls is prohibited. Drip pans must be used under all equipment where there is a possibility of leakage. No helium-filled balloons or adhesive-backed stickers hotel space may be used by exhibitor or given out by Suppliersany of its affiliated organizations for any business, social, or other event without the prior written approval of ICI. Because this No functions may conflict with the conference’s meeting agenda, Exhibit Hall hours, conference registration, and reception/dinner times. INSTALLATION/DISMANTLING AND EXHIBIT HOURS Tuesday, February 6 8:00 a.m.–4:00 p.m. Wednesday, February 7 8:30 a.m.–6:30 p.m. Thursday, February 8 7:30 a.m.–3:15 p.m. Thursday, February 8 3:15–9:00 p.m. These dates and times are subject to change. If it is a networking and education focused forumnecessary to change the exhibit hours, there exhibitor will be no equipment or machinery allowed on display in the Supplier Suite or at your Collaboration Kiosknotified before Monday, unless approved by SHOW MANAGEMENTDecember 4, 2023. FDA APPROVAL/CLEARANCE: If a Supplier intends to display, introduce or feature an article whose pre-market approval or clearance is pending from the U.S. Food & Drug Administration, the Supplier’s materials, and the Supplier’s personnel must disclose that such article has not received final FDA approval/clearance and clearly conveyed the status of such article consistent with such laws, rules and regulations administrated by the FDA. The Supplier Suite or Collaboration Kiosk displays and any associated materials also must adequately and completely disclose that the article is not currently available for sale or commercial distribution in the U.S. shall indemnify and hold harmless SHOW MANAGEMENT and the Convening Organization(s) from and against any and all costs, fees, expenses, penalties, damages and claims arising from Supplier’s failure to comply with all laws, rules and regulations (including those of FDA) applicable to such article (including any law, rule or regulation governing the display, introduction, or advertising of such article prior to final FDA approval/clearance).ICI InTnAovCate